These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28060721)

  • 1. DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis.
    Yang X; Zhang X; Wu R; Huang Q; Jiang Y; Qin J; Yao F; Jin G; Zhang Y
    Oncotarget; 2017 Jan; 8(5):8679-8692. PubMed ID: 28060721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
    Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
    PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis.
    Tan CW; Lee YH; Tan HH; Lau MS; Choolani M; Griffith L; Chan JK
    Fertil Steril; 2014 Jul; 102(1):167-177.e9. PubMed ID: 24825423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase IV is required for endometrial carcinoma cell proliferation and tumorigenesis via the IL-6/STAT3 pathway.
    Yang X; Zhu Y; Shi Q; Zhao X; Huang Y; Yao F; Zhang Y; Wang Z
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2449-2459. PubMed ID: 33969570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells.
    Wesley UV; Tiwari S; Houghton AN
    Int J Cancer; 2004 May; 109(6):855-66. PubMed ID: 15027119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
    Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
    Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade.
    Khin EE; Kikkawa F; Ino K; Kajiyama H; Suzuki T; Shibata K; Tamakoshi K; Nagasaka T; Mizutani S
    Am J Obstet Gynecol; 2003 Mar; 188(3):670-6. PubMed ID: 12634639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
    Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
    Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
    Li Y; Jia Y; Che Q; Zhou Q; Wang K; Wan XP
    Oncotarget; 2015 Sep; 6(28):26373-87. PubMed ID: 26308071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV in tumor progression.
    Kikkawa F; Kajiyama H; Shibata K; Ino K; Nomura S; Mizutani S
    Biochim Biophys Acta; 2005 Aug; 1751(1):45-51. PubMed ID: 16054016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma.
    Kajiyama H; Kikkawa F; Suzuki T; Shibata K; Ino K; Mizutani S
    Cancer Res; 2002 May; 62(10):2753-7. PubMed ID: 12019149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
    Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
    Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.
    Kikkawa F; Kajiyama H; Ino K; Shibata K; Mizutani S
    Int J Cancer; 2003 Jul; 105(6):779-83. PubMed ID: 12767062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
    Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
    PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
    Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
    Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells.
    Kajiyama H; Kikkawa F; Khin E; Shibata K; Ino K; Mizutani S
    Cancer Res; 2003 May; 63(9):2278-83. PubMed ID: 12727850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells.
    Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
    Ann N Y Acad Sci; 2006 Nov; 1086():233-40. PubMed ID: 17185520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphenol A-induced epithelial to mesenchymal transition is mediated by cyclooxygenase-2 up-regulation in human endometrial carcinoma cells.
    Wang KH; Kao AP; Chang CC; Lin TC; Kuo TC
    Reprod Toxicol; 2015 Dec; 58():229-33. PubMed ID: 26546977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.